No Data
No Data
Form 144 | Monte Rosa Therapeutics(GLUE.US) Officer Proposes to Sell 813.89K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 10, $Monte Rosa Therapeutics(GLUE.US)$ Officer Jones Jullian G intends to sell 103.55K shares of its common stock on Apr 10, with a total market value of approximately $813
Monte Rosa Therapeutics (GLUE) Gets a Buy From Piper Sandler
Does Monte Rosa Therapeutics (GLUE) Have the Potential to Rally 107.79% as Wall Street Analysts Expect?
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersStoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out
Monte Rosa Therapeutics (NASDAQ:GLUE) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose mo
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Moderna (MRNA) and Monte Rosa Therapeutics (GLUE)
No Data